Association between the ENPP1 K121Q polymorphism and risk of diabetic kidney disease: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Sortica, Denise Alves ^a,b   Buffon, Marjorie Piucco ^a,b   Souza, Bianca Marmontel ^a,b   Nicoletto, Bruna Bellicanta ^a,b   Santer, Andressa ^a   Assmann, Tais Silveira ^a,b   Crispim, Daisy ^a,b   Canani, Luis Henrique ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; PHOSPHODIESTERASE; UNCLASSIFIED DRUG; INORGANIC PYROPHOSPHATASE;

ALLELE; ARTICLE; ASIAN; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; ENPP1 GENE; EUROPEAN; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTEMATIC REVIEW; AMINO ACID SUBSTITUTION; BIOLOGICAL MODEL; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; INHERITANCE; META ANALYSIS; ODDS RATIO; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; DIABETIC NEPHROPATHIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; MODELS, GENETIC; ODDS RATIO; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PYROPHOSPHATASES; RISK FACTORS;

EID: 84925600882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118416     Document Type: Article

References (66)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94: 311-321. doi: 10.1016/j.diabres.2011. 10.029 PMID: 22079683
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009; 32: 62.
3. Mima A. Inflammation and oxidative stress in diabetic nephropathy: New insights on its inhibition as new therapeutic targets. J Diabetes Res. 2013; 2013: 248563. doi: 10.1155/2013/248563 PMID: 23862164
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013; Suppl: S1-S150.
5. Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014; 63: S39-62. doi: 10.1053/j.ajkd.2013.10.048 PMID: 24461729
6. Carpena MP, Rados DV, Sortica DA, Souza BM, Reis AF, Canani LH et al. Genetics of diabetic nephropathy. Arq Bras Endocrinol Metabol. 2010; 54: 253-261. PMID: 20520954
7. Sortica DA, Crispim D, Zaffari GP, Friedman R, Canani LH. The role of ecto-nucleotide pyrophosphatase/ phosphodiesterase 1 in diabetic nephropathy. Arq Bras Endocrinol Metabol. 2011; 55: 677-685. PMID: 22231969
8. Thomas MC, Groop PH, Tryggvason K. Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens. 2012; 21: 195-202. doi: 10.1097/MNH. 0b013e328350313e PMID: 22314557
9. Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol. 2007; 2: 1306-1316. PMID: 17942768
10. Leitao CB, Nabinger GB, Krahe AL, Bolson PB, Gerchman F, Gross JL, et al. The role of K121Q ENPP1 polymorphism in diabetes mellitus and its complications. Braz J Med Biol Res. 2008; 41: 229-234. PMID: 18176722
11. Bacci S, Ludovico O, Prudente S, Zhang YY, Di Paola R, Mangiacotti D, et al. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes. 2005; 54: 3021-3025. PMID: 16186408
12. Pizzuti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, Bozzali M, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999; 48: 1881-1884. PMID: 10480624
13. Meyre D, Bouatia-Naji N, Tounian A, Samson C, Lecoeur C, Vatin V, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005; 37: 863-867. PMID: 16025115
14. Palmer ND, Freedman BI. Insights into the genetic architecture of diabetic nephropathy. Curr Diab Rep. 2012; 12: 423-431. doi: 10.1007/s11892-012-0279-2 PMID: 22573336
15. De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant. 2013; 28: 29-36. doi: 10.1093/ndt/gfs290 PMID: 23048172
16. Buckley MF, Loveland KA, McKinstry WJ, Garson OM, Goding JW. Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. J Biol Chem. 1990; 265: 17506-17511. PMID: 2211644
17. Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol. 2000; 35: 393-432. PMID: 11202013
18. Canani LH, Ng DP, Smiles A, Rogus JJ, Warram JH, Krolewski AS. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes. 2002; 51: 1188-1193. PMID: 11916943
19. Wu LS, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant. 2009; 24: 3360-3366. doi: 10.1093/ ndt/gfp271 PMID: 19506043
20. De Cosmo S, Minenna A, Zhang YY, Thompson R, Miscio G, Vedovato M, et al. Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes. Am J Kidney Dis. 2009; 53: 273-280. doi: 10.1053/j.ajkd.2008.07.040 PMID: 18950909
21. Lin CC, Wu CT, Wu LS. Ectonucleotide pyrophosphatase/phosphodiesterase 1 K173Q polymorphism is associated with diabetic nephropathy in the Taiwanese population. Genet Test Mol Biomarkers. 2011; 15: 239-242. doi: 10.1089/gtmb.2010.0148 PMID: 21198320
22. Jacobsen P, Grarup N, Tarnow L, Parving HH, Pedersen O. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients. Nephrol Dial Transplant. 2002; 17: 1408-1412. PMID: 12147787
23. Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, et al. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes. 2008; 57: 1057-1062. doi: 10. 2337/db07-0886 PMID: 18184924
24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med. 2009; 151: 264-269, W264. PMID: 19622511
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012. PMID: 10789670
26. de Souza BM, Brondani LA, Boucas AP, Sortica DA, Kramer CK, Canani LH, et al. Associations between UCP1-3826A/G, UCP2-866G/A, Ala55Val and Ins/Del, and UCP3-55C/T polymorphisms and susceptibility to type 2 diabetes mellitus: Case-control study and meta-analysis. 2013; PLoS One 8: e54259. doi: 10.1371/journal.pone.0054259 PMID: 23365654
27. Brondani LA, Assmann TS, de Souza BM, Boucas AP, Canani LH, Crispim D. Meta-Analysis Reveals the Association of Common Variants in the Uncoupling Protein (UCP) 1-3 Genes with Body Mass Index Variability. PLoS One. 2014; 9: e96411. doi: 10.1371/journal.pone.0096411 PMID: 24804925
28. Boucas AP, Brondani LA, Souza BM, Lemos NE, de Oliveira FS, Canani LH, et al. The A allele of the rs1990760 polymorphism in the IFIH1 gene is associated with protection for arterial hypertension in type 1 diabetic patients and with expression of this gene in human mononuclear cells. PLoS One. 2013; 8: e83451. doi: 10.1371/journal.pone.0083451 PMID: 24386202
29. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25: 603-605. doi: 10.1007/s10654-010-9491-z PMID: 20652370
30. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J. The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol. 2005; 34: 1319-1328. PMID: 16115824
31. Higgins JP, Spiegelhalter DJ. Being sceptical about meta-analyses: A Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol. 2002; 31: 96-104. PMID: 11914302
32. Tarnow L, Grarup N, Hansen T, Parving HH, Pedersen O. Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant. 2001; 16: 1653-1656. PMID: 11477169
33. Keshavarz P, Inoue H, Sakamoto Y, Kunika K, Tanahashi T, Nakamura N, et al. No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population. J Hum Genet. 2006; 51: 559-566. PMID: 16607460
34. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature. 1995; 373: 448-451. PMID: 7830796
35. Maddux BA, Goldfine ID. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes. 2000; 49: 13-19. PMID: 10615944
36. Frittitta L, Youngren JF, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, et al. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-alpha gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia. 1997; 40: 282-289. PMID: 9084965
37. Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia. 1996; 39: 1190-1195. PMID: 8897006
38. Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, et al. Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport. Diabetes. 1996; 45: 1324-1328. PMID: 8826966
39. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R. et al. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes. 1998; 47: 1095-1100. PMID: 9648833
40. Maddux BA, Chang YN, Accili D, McGuinness OP, Youngren JF, Goldfine ID. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. Am J Physiol Endocrinol Metab. 2006; 290: E746-749. PMID: 16278247
41. Zhou HH, Chin CN, Wu M, Ni W, Quan S, Liu F, et al. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. Eur J Pharmacol. 2009; 616: 346-352. doi: 10.1016/j. ejphar.2009.06.057 PMID: 19577557
42. Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes. 2005; 54: 1207-1213. PMID: 15793263
43. Grarup N, Urhammer SA, Ek J, Albrechtsen A, Glumer C, Borch-Johnsen K, et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia. 2006; 49: 2097-2104. PMID: 16865358
44. Berhouma R, Kouidhi S, Ammar M, Abid H, Baroudi T, Baroudi T, et al. Genetic susceptibility to type 2 diabetes: A global meta-analysis studying the genetic differences in Tunisian populations. Hum Biol. 2012; 84: 423-435. doi: 10.3378/027.084.0405 PMID: 23249316
45. Jing C, Xueyao H, Linong J. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. Endocrine. 2012; 42: 307-320. PMID: 22391941
46. Li YY. ENPP1 K121Q polymorphism and type 2 diabetes mellitus in the Chinese population: A metaanalysis including 11,855 subjects. Metabolism. 2012; 61: 625-633. doi: 10.1016/j.metabol.2011.10. 002 PMID: 22136912
47. McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN, Trischitta V, et al. The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated metaanalysis in 42,042 subjects. Diabetes. 2012; 57: 1125-1130.
48. Wang M, Peng C, Qu YL, Huang QY. [Association and meta-analysis of ENPP1 K121Q with type 2 diabetes in Han Chinese.]. Yi Chuan. 2010; 32: 808-816. PMID: 20709678
49. Zhao T, Liu Z, Zhang D, Liu Y, Yang Y, Zhou D, et al. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes or obesity in the Chinese Han population. J Hum Genet. 2011; 56: 12-16. doi: 10.1038/jhg.2010.124 PMID: 20981035
50. Weedon MN, Shields B, Hitman G, Walker M, McCarthy MI, Hattersley AT, et al. No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes. 2006; 55: 3175-3179. PMID: 17065358
51. De Cosmo S, Argiolas A, Miscio G, Thomas S, Piras GP, Trevisan R, et al. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria. Diabetes. 2000; 49: 521-524. PMID: 10868979
52. Arar NH, Voruganti VS, Nath SD, Thameem F, Bauer R, Cole SA, et al. A genome-wide search for linkage to chronic kidney disease in a community-based sample: the SAFHS. Nephrol Dial Transplant. 2008; 23: 3184-3191. doi: 10.1093/ndt/gfn215 PMID: 18443212
53. Craig DW, Millis MP, DiStefano JK. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes. Diabet Med. 2009; 26: 1090-1098. doi: 10.1111/j.1464-5491.2009.02846.x PMID: 19929986
54. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008; 40: 1185-1192. doi: 10.1038/ng. 232 PMID: 18794854
55. Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, et al. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach. Diabetes. 2008; 57: 2519-2526. doi: 10.2337/db07-1086 PMID: 18559660
56. Freedman BI, Bowden DW, Rich SS, Valis CJ, Sale MM, Hicks PJ, et al. A genome scan for all-cause end-stage renal disease in African Americans. Nephrol Dial Transplant. 2005; 20: 712-718. PMID: 15701670
57. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, Walker W, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int. 2006; 69: 129-136. PMID: 16374433
58. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, et al. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes. 2008; 57: 235-243. PMID: 18003762
59. Chen G, Adeyemo AA, Zhou J, Chen Y, Doumatey A, Lashley K, et al. A genome-wide search for linkage to renal function phenotypes in West Africans with type 2 diabetes. Am J Kidney Dis. 2007; 49: 394-400. PMID: 17336700
60. Igo RP Jr, Iyengar SK, Nicholas SB, Goddard KA, Langefeld CD, Hanson RL, et al. Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol. 2011; 33: 381-389. doi: 10.1159/000326763 PMID: 21454968
61. Murea M, Lu L, Ma L, Hicks PJ, Divers J, McDonough CW, et al. Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. Am J Nephrol. 2011; 33: 502-509. doi: 10. 1159/000327985 PMID: 21546767
62. Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, et al. Genetic associations in diabetic nephropathy: A meta-analysis. Diabetologia. 2011; 54: 544-553. doi: 10.1007/s00125-010-1996-1 PMID: 21127830
63. Goding JW, Howard MC. Ecto-enzymes of lymphoid cells. Immunol Rev. 1998; 161: 5-10. PMID: 9601561
64. Gu HF, Almgren P, Lindholm E, Frittitta L, Pizzuti A, Trischitta V, et al. Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes. 2000; 49: 1601-1603. PMID: 10969847
65. Abate N. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications. 2000; 14: 154-174. PMID: 10989324
66. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab. 2001; 86: 713-718. PMID: 11158035